论文部分内容阅读
对国产抗A、抗B单抗血型试剂进行了质量、稳定性、与亚型细胞识别检定及临床应用。临床应用对象包括1岁及1岁以下婴儿、59及59岁以上老人、肿瘤患者及非肿瘤患者、健康献血员、少数民族人群。共414044人，正反定型及与人血清试剂相符率为99．998％。质量及临床应用结果表明，我国单抗血型定型试剂，已达到人血型定型试剂要求，可以取代人血清型试剂推广应用。
The domestic anti-A, anti-B monoclonal antibody blood quality, stability, and sub-type cell identification test and clinical application. Clinical applications include infants under 1 and under 1, aged 59 and 59, cancer patients and non-tumor patients, healthy blood donors, ethnic minority populations. A total of 414044 people, positive and negative stereotypes and human serum reagents in line with the rate of 99.998%. The results of quality and clinical application show that the single blood grouping type reagent in our country has reached the requirement of human blood type setting reagent and can replace the promotion and application of human serum type reagent.